Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Hepatitis

  Free Subscription


15.07.2024

2 Am J Gastroenterol
1 Dig Dis Sci
2 Eur J Gastroenterol Hepatol
1 Gut
1 Hepatology
1 J Clin Gastroenterol
5 J Hepatol
2 J Infect Dis
1 J Med Virol
1 J Viral Hepat
4 PLoS One
1 PLoS Pathog
1 Transplant Proc
1 Vaccine


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Gastroenterol

  1. DUKEWICH M, Dodge JL, Lucey MR, Rice JP, et al
    The Survival Benefit of Re-abstinence After Harmful Alcohol Use Following Early Liver Transplant for Severe Alcohol-Associated Hepatitis: A Multi-Center ACCELERATE Study.
    Am J Gastroenterol. 2024 Jul 12. doi: 10.14309/ajg.0000000000002956.
    PubMed         Abstract available

  2. LEE WM, Barnard C, Rule JA, Orandi BJ, et al
    Association of Acetaminophen (Paracetamol) Use with Severity and Outcomes in Patients with Viral Hepatitis-Associated Acute Liver Failure.
    Am J Gastroenterol. 2024 Jul 12. doi: 10.14309/ajg.0000000000002941.
    PubMed         Abstract available


    Dig Dis Sci

  3. MAKOVICH Z, Radosavljevic I, Chapyala S, Handley G, et al
    Rationale for Hepatitis C Virus Treatment During Hematopoietic Stem Cell Transplant in the Era of Novel Direct-Acting Antivirals.
    Dig Dis Sci. 2024 Jul 11. doi: 10.1007/s10620-024-08541.
    PubMed         Abstract available


    Eur J Gastroenterol Hepatol

  4. LIN CY, Sun WC, Lu CM, Chen WC, et al
    Entecavir vs. tenofovir disoproxil fumarate in the treatment of chronic hepatitis B patients with severe acute exacerbation.
    Eur J Gastroenterol Hepatol. 2024 Jun 26. doi: 10.1097/MEG.0000000000002709.
    PubMed         Abstract available

  5. WANG FC, Dong Y, Xu ZQ, Gao YJ, et al
    Characteristics analysis of hepatitis B core-related antigen in children with hepatitis B e antigen-positive chronic viral hepatitis B infection.
    Eur J Gastroenterol Hepatol. 2024 Jun 28. doi: 10.1097/MEG.0000000000002812.
    PubMed         Abstract available


    Gut

  6. BAUMERT T, Urbanek-Quaing M, Cornberg M
    Immunomodulation and entry inhibition: selgantolimod's double punch against hepatitis B virus.
    Gut. 2024 Jul 5:gutjnl-2024-332679. doi: 10.1136/gutjnl-2024-332679.
    PubMed        


    Hepatology

  7. QIAN J, Xie Y, Mao Q, Xie Q, et al
    A randomized phase 2b study of subcutaneous PD-L1 antibody ASC22 in virally-suppressed, HBeAg negative chronic hepatitis B patients.
    Hepatology. 2024 Jul 8. doi: 10.1097/HEP.0000000000001006.
    PubMed         Abstract available


    J Clin Gastroenterol

  8. LI M, Yao M, Wang L, Liu Y, et al
    The Early On-treatment Stiffness Decline Attributed to the Improved Hepatic Inflammation in Fibrotic Chronic Hepatitis B.
    J Clin Gastroenterol. 2024 Jul 11. doi: 10.1097/MCG.0000000000002032.
    PubMed         Abstract available


    J Hepatol

  9. ZOULIM F, Chen PJ, Dandri M, Kennedy P, et al
    Hepatitis B Virus DNA integration: Implications for diagnostics, therapy, and outcome.
    J Hepatol. 2024 Jul 4:S0168-8278(24)02343-2. doi: 10.1016/j.jhep.2024.
    PubMed         Abstract available

  10. TAK WY, Chuang WL, Chen CY, Tseng KC, et al
    Phase 1b/2a randomized study of heterologous ChAdOx1-HBV/MVA-HBV therapeutic vaccination (VTP-300) as monotherapy and combined with low-dose nivolumab in virally-suppressed patients with chronic hepatitis B.
    J Hepatol. 2024 Jul 5:S0168-8278(24)02333-X. doi: 10.1016/j.jhep.2024.
    PubMed         Abstract available

  11. KUNDU J, Le HT, Logan M, Hockman D, et al
    Recombinant H77C gpE1/gpE2 heterodimer elicits superior HCV cross-neutralisation than H77C gpE2 alone.
    J Hepatol. 2024 Jul 8:S0168-8278(24)02335-3. doi: 10.1016/j.jhep.2024.
    PubMed         Abstract available

  12. ZHANG JW, Lai RM, Wang LF, Wang SL, et al
    Varied immune responses of HBV-specific B cells in patients undergoing pegylated interferon-alpha treatment for chronic hepatitis B.
    J Hepatol. 2024 Jul 9:S0168-8278(24)02338-9. doi: 10.1016/j.jhep.2024.
    PubMed         Abstract available

  13. MINAMI T, Fujishiro M, Tateishi R
    Reply to: "Validation of SMART Model for HCC Risk stratification in genotype -4 HCV Patients following SVR and its comparison with GES score".
    J Hepatol. 2024 Jul 9:S0168-8278(24)02361-4. doi: 10.1016/j.jhep.2024.
    PubMed        


    J Infect Dis

  14. NAKAYA Y, Onomura D, Hoshi Y, Yamagata T, et al
    Establishment of a hepatitis B virus reporter system harboring a HiBiT-tag in the PreS2 region.
    J Infect Dis. 2024 Jul 11:jiae353. doi: 10.1093.
    PubMed         Abstract available

  15. YAO Z, Gu Y, Lai X, Yang M, et al
    Trajectories of serum HBsAg during treatment and association with HBsAg loss in children with HBeAg-positive chronic hepatitis B: a latent class trajectory analysis.
    J Infect Dis. 2024 Jul 5:jiae349. doi: 10.1093.
    PubMed         Abstract available


    J Med Virol

  16. CASTRO V, Calvo G, Oliveros JC, Perez-Del-Pulgar S, et al
    Hepatitis C virus-induced differential transcriptional traits in host cells after persistent infection elimination by direct-acting antivirals in cell culture.
    J Med Virol. 2024;96:e29787.
    PubMed         Abstract available


    J Viral Hepat

  17. BEYDOUN HA, Tsai J
    Screening rates for hepatitis B and C among low-income US veterans: Data from the National Veteran Homeless and Other Poverty Experiences Study.
    J Viral Hepat. 2024 Jul 10. doi: 10.1111/jvh.13981.
    PubMed         Abstract available


    PLoS One

  18. YIRSAW BG, Agimas MC, Alemu GG, Tesfie TK, et al
    Prevalence of Hepatitis B virus infection and its determinants among pregnant women in East Africa: Systematic review and Meta-analysis.
    PLoS One. 2024;19:e0307102.
    PubMed         Abstract available

  19. GIKUNYU CW, Mbogori E, Kwena A, Maiyoh GK, et al
    Prevalence of HBV genotypes among patients attending Moi Teaching and Referral Hospital liver clinic.
    PLoS One. 2024;19:e0305753.
    PubMed         Abstract available

  20. KITIL GW, Dubale AT, Shibabaw AA, Chereka AA, et al
    Practices for preventing Hepatitis B infection among health science students in Ethiopia: Systematic review and meta-analysis.
    PLoS One. 2024;19:e0306965.
    PubMed         Abstract available

  21. YOUNES N, Chemaitelly H, Nizamuddin PB, Al-Hamad T, et al
    Prevalence of hepatitis A virus among migrant workers in Qatar: A national study.
    PLoS One. 2024;19:e0306753.
    PubMed         Abstract available


    PLoS Pathog

  22. GRIESMAN T, McMillen CM, Negatu SG, Hulahan JJ, et al
    The lipopeptide Pam3CSK4 inhibits Rift Valley fever virus infection and protects from encephalitis.
    PLoS Pathog. 2024;20:e1012343.
    PubMed         Abstract available


    Transplant Proc

  23. DE ATAIDE EC, Perales SR, Bento APN, Teramoto FD, et al
    Silent Destruction: Fulminant Hepatitis and the Hidden Danger of Weight Loss Drugs.
    Transplant Proc. 2024 Jul 4:S0041-1345(24)00268.
    PubMed         Abstract available


    Vaccine

  24. MESHRAM R, Kolte B, Gacche R
    Reverse vaccinology approach for identification of epitopes from E1 protein as peptide vaccine against HCV: A proof of concept.
    Vaccine. 2024 Jul 5:S0264-410X(24)00747-3. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.